BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會


Dorthe Mikkelsen


Session 12 – Recent Development of Game-Changing Tumor Agnostic Therapeutics

Date:23 July (Friday)
Time:  12:20 – 13:50 (GMT+8)

Dorthe Mikkelsen 

President, Asia Pacific, MSD

Ms. Mikkelsen is President of MSD in Asia Pacific, which has over 7,000 employees across 12 markets. She is an executive ambassador for MSD for Mothers, MSD’s 10-year, $500 million initiative focused on improving maternal health. Ms. Mikkelsen joined MSD in Denmark in 1997. She previously has served as Senior Vice President for MSD’s Mid-Europe region. Before becoming Asia Pacific President, she led Global Diversified Brands at Merck & Co., Inc. Kenilworth, NJ, USA. Ms. Mikkelsen also has served in leadership roles in several industry associations. She currently serves on the Board of Directors for several organizations, including the US-ASEAN Business Council, the premier advocacy organization for U.S. corporations operating within the Association of Southeast Asian Nations (ASEAN). Ms. Mikkelsen was named one of the 100 Most Influential Women in Denmark by Berlingske in 2019. She was named to the Business Insider list of 100 people Transforming Business in Asia in 2020. Ms. Mikkelsen holds a Master of Science in Pharmacy from the Royal Danish School of Pharmacy and a Diploma in Business Economics from Copenhagen Business School.


Speech title & Synopsis

Expand patient access - The next brave step:
Innovation in immuno-oncology and the opportunity for change for patients